105 related articles for article (PubMed ID: 10536809)
21. The efficacy of diazepam in enhancing motor function in children with spastic cerebral palsy.
Mathew A; Mathew MC; Thomas M; Antonisamy B
J Trop Pediatr; 2005 Apr; 51(2):109-13. PubMed ID: 15840761
[TBL] [Abstract][Full Text] [Related]
22. Epilepsy and intrathecal baclofen therapy in children with cerebral palsy.
Buonaguro V; Scelsa B; Curci D; Monforte S; Iuorno T; Motta F
Pediatr Neurol; 2005 Aug; 33(2):110-3. PubMed ID: 16087055
[TBL] [Abstract][Full Text] [Related]
23. [Quality of life in cerebral palsy children treated with intrathecal baclofen pump implantation in parents' opinion].
Borowski A; Pruszczyński B; Miller F; Synder M
Chir Narzadow Ruchu Ortop Pol; 2010; 75(5):318-22. PubMed ID: 21853903
[TBL] [Abstract][Full Text] [Related]
24. Placebo controlled utility and feasibility study of the H-reflex and flexor reflex in spastic children treated with intrathecal baclofen.
Hoving MA; van Kranen-Mastenbroek VH; van Raak EP; Spincemaille GH; Hardy EL; Vles JS;
Clin Neurophysiol; 2006 Jul; 117(7):1508-17. PubMed ID: 16759902
[TBL] [Abstract][Full Text] [Related]
25. Mechanical measurements of the effects of intrathecal baclofen dosage adjustments in cerebral palsy: a pilot study.
Schmit BD; Gaebler-Spira D
Am J Phys Med Rehabil; 2004 Jan; 83(1):33-41. PubMed ID: 14709973
[TBL] [Abstract][Full Text] [Related]
26. The role of intrathecal baclofen in the management of primary and secondary dystonia in children.
Woon K; Tsegaye M; Vloeberghs MH
Br J Neurosurg; 2007 Aug; 21(4):355-8. PubMed ID: 17676454
[TBL] [Abstract][Full Text] [Related]
27. Upper limb function after intrathecal baclofen treatment in children with cerebral palsy.
Motta F; Stignani C; Antonello CE
J Pediatr Orthop; 2008; 28(1):91-6. PubMed ID: 18157052
[TBL] [Abstract][Full Text] [Related]
28. Changes in soleus H-reflex modulation after treadmill training in children with cerebral palsy.
Hodapp M; Vry J; Mall V; Faist M
Brain; 2009 Jan; 132(Pt 1):37-44. PubMed ID: 18984603
[TBL] [Abstract][Full Text] [Related]
29. The effects of continuous intrathecal baclofen infusion in non-ambulant children with cerebral palsy.
Miller F
Dev Med Child Neurol; 2011 Aug; 53(8):679-80. PubMed ID: 21707603
[No Abstract] [Full Text] [Related]
30. Intrathecal baclofen in children with spastic cerebral palsy: a double-blind, randomized, placebo-controlled, dose-finding study.
Hoving MA; van Raak EP; Spincemaille GH; Palmans LJ; Sleypen FA; Vles JS;
Dev Med Child Neurol; 2007 Sep; 49(9):654-9. PubMed ID: 17718820
[TBL] [Abstract][Full Text] [Related]
31. Dantrolene: new indication. Cerebral palsy in children: uncertain clinical benefit.
Prescrire Int; 2008 Dec; 17(98):237. PubMed ID: 19422149
[TBL] [Abstract][Full Text] [Related]
32. [Botulinum toxin type A in the treatment plan for cerebral palsy].
Strobl W
Wien Klin Wochenschr; 2001; 113 Suppl 4():30-5. PubMed ID: 15506050
[TBL] [Abstract][Full Text] [Related]
33. Baclofen infusion for spastic cerebral palsy.
Steinbok P; O'Donnnell M
Clin Neurosurg; 2000; 47():440-57. PubMed ID: 11197716
[No Abstract] [Full Text] [Related]
34. Improvements in children with cerebral palsy following intrathecal baclofen: use of the Rehabilitation Institute of Chicago Care and Comfort Caregiver Questionnaire (RIC CareQ).
Baker KW; Tann B; Mutlu A; Gaebler-Spira D
J Child Neurol; 2014 Mar; 29(3):312-7. PubMed ID: 23420651
[TBL] [Abstract][Full Text] [Related]
35. Treatment of children with cerebral palsy.
Dai AI
J Pediatr Orthop B; 2007 Jul; 16(4):303. PubMed ID: 17527111
[No Abstract] [Full Text] [Related]
36. Neurophysiological changes induced by the botulinum toxin type A injection in children with cerebral palsy.
Frascarelli F; Di Rosa G; Bisozzi E; Castelli E; Santilli V
Eur J Paediatr Neurol; 2011 Jan; 15(1):59-64. PubMed ID: 20493744
[TBL] [Abstract][Full Text] [Related]
37. Electrophysiological assessment of the effect of intrathecal baclofen in dystonic children.
Dachy B; Dan B
Clin Neurophysiol; 2004 Apr; 115(4):774-8. PubMed ID: 15003756
[TBL] [Abstract][Full Text] [Related]
38. [Spasticity in children cerebral palsy: diagnosis and treatment strategies].
Kurenkov AL; Batysheva TT; Vinogradov AV; Ziuziaeva EK
Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(7 Pt 2):24-8. PubMed ID: 23330188
[TBL] [Abstract][Full Text] [Related]
39. [A role of segmental disturbances in formation of movement disorders in patients with infantile cerebral palsy].
Kurenkov AL
Zh Nevrol Psikhiatr Im S S Korsakova; 2004; 104(2):16-20. PubMed ID: 15002315
[TBL] [Abstract][Full Text] [Related]
40. [The usefulness of tizanidine. A one-year follow-up of the treatment of spasticity in infantile cerebral palsy].
Vásquez-Briceño A; Arellano-Saldaña ME; León-Hernández SR; Morales-Osorio MG
Rev Neurol; 2006 Aug 1-15; 43(3):132-6. PubMed ID: 16871477
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
